Nature Communications (Apr 2017)

Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria

  • Stefano Pegoraro,
  • Maëlle Duffey,
  • Thomas D. Otto,
  • Yulin Wang,
  • Roman Rösemann,
  • Roland Baumgartner,
  • Stefanie K. Fehler,
  • Leonardo Lucantoni,
  • Vicky M. Avery,
  • Alicia Moreno-Sabater,
  • Dominique Mazier,
  • Henri J. Vial,
  • Stefan Strobl,
  • Cecilia P. Sanchez,
  • Michael Lanzer

DOI
https://doi.org/10.1038/ncomms15273
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 2

Abstract

Read online

Nature Communications 8 Article number:14193 (2017); Published 31 January 2017; Updated 6 Apr 2017 This Article contains errors in Figs. 1 and 8 that were introduced during the production process. The compound on the lower right side of Fig. 1 is labelled incorrectly and should be labelled ‘SC83288’. The correct version of Fig.